For citations:

Sviridenko N.Y., Ananicheva E.V., Gershevich V.M., Grusha Y.O., Chepilev K.A., Surov A.V., Yurgel V.V., Shchukin K.S., Bessmertnaya E.G., Bilevich O.A. The use of tocilizumab in severe glucocorticoid-resistant endocrine ophthalmopathy with optic neuropathy in clinical practice. Problems of Endocrinology. 2025;71(6):31-39. (In Russ.) https://doi.org/10.14341/probl13580